PIONEERING ANTI-TUMOR IMMUNE REDIRECTION

Redirecting immune memory from pathogens or childhood vaccines to target cancer.

 
homepage-navy.jpg

WHAT SETS US APART

Anti-tumor Immune Redirection

VerImmune is developing Anti-Tumor Immune Redirection (AIR): a breakthrough therapy that redirects immune memory against pathogens or childhood vaccines to target cancer.

 

LEARN MORE

We’re always looking to connect with others in in the industry.

 
infograhpic.png

IMMUNE MEMORY DEVELOPMENT

Long-lasting immune memory stems from childhood vaccines or past viral infections.

infographic2.png

CANCER DIAGNOSIS

Pre-existing immune memory is retained to adulthood when diagnosed with cancer.

infographic3.png

ANTI-TUMOR IMMUNE REDIRECTION (AIR)

AIR therapy leverages
and redirects pre-existing immune memory
towards cancer.

infographic4.png

CANCER DESTRUCTION

Redirected pre-existing immunity leads to tumor cell death.


The Need


 

+14M

new cases per year and growing

 

$100B

per annum spent on cancer medicines

 

$800B

per annum spent on cancer care

 
 

Our Strategy


 
 
Graphic1.jpg

PATIENT SELECTION

Screen for pre-existing immunity from infection or childhood vaccine (potential biomarker)

TREATMENT

AIR modifies tumor cells to appear as virally infected cells

OUTCOME

Tumor cell death via immune redirection of patient’s viral memory CD8+ T cells